LH - Labcorp Holdings Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $4.09
|
Rev Est: $3.5B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$315.38
DETAILS
HIGH:
$342.00
LOW:
$290.00
MEDIAN:
$320.00
CONSENSUS:
$315.38
UPSIDE:
9.84%
Market Cap:
23.80B
Volume:
459,728
Avg Volume:
739,960
52 Week Range:
209.38-293.72
Sector:
Healthcare
Industry:
Medical - Equipment & Services
Beta:
1.00
Last Dividend:
$2.88
Exchange:
NYSE
Country:
US
Employees:
60,900
IPO Date:
1990-03-29
EPS (TTM):
10.54
P/E Ratio:
23.81
Revenue (TTM):
13.95B
Total Assets:
18.39B
Total Debt:
7.20B
Cash & Equiv:
532.30M
Rev Growth (5Y):
-0.0%
EPS Growth (5Y):
-8.0%
FCF Growth (5Y):
-7.2%
ROCE:
9.7%
Debt/Equity:
0.84
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $4.07 | $3.95 | +3.0% | $3.5B | $3.5B | +0.5% |
| 2025-10-28 | $4.18 | $4.13 | +1.2% | $3.6B | $3.6B | +0.2% |
| 2025-07-24 | $4.35 | $4.17 | +4.3% | $3.5B | $3.5B | +1.2% |
| 2025-04-29 | $3.84 | $3.74 | +2.7% | $3.3B | $3.4B | -1.6% |
| 2025-02-06 | $3.45 | $3.39 | +1.8% | $3.3B | $3.3B | +0.7% |
| 2024-10-24 | $3.50 | $3.47 | +0.9% | $3.3B | $3.3B | +0.6% |
| 2024-08-01 | $3.94 | $3.78 | +4.2% | $3.2B | $3.2B | +1.1% |
| 2024-04-25 | $3.68 | $3.48 | +5.7% | $3.2B | $3.1B | +1.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B | 11.55B | 11.33B | 10.44B | 9.64B | 8.68B | 6.01B |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B | 1.56B | 823.80M | 883.70M | 1.27B | 732.10M | 436.90M | 511.20M |
| EPS | 10.54 | 8.89 | 4.80 | 14.04 | 24.58 | 15.99 | 8.41 | 8.71 | 12.39 | 7.14 | 4.42 | 6.03 |
| Total Assets | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B | 20.07B | 18.02B | 16.19B | 16.57B | 14.25B | 14.29B | 7.30B |
| Total Debt | 7.20B | 7.27B | 5.95B | 6.25B | 6.34B | 6.76B | 7.11B | 6.06B | 6.76B | 5.85B | 6.36B | 3.03B |
| Cash & Equivalents | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B | 1.32B | 337.50M | 426.80M | 316.60M | 433.60M | 716.40M | 580.00M |
| Operating Cash Flow | 1.64B | 1.59B | 1.33B | 1.96B | 3.11B | 2.14B | 1.44B | 1.31B | 1.46B | 1.18B | 982.40M | 739.00M |
| Free Cash Flow | 1.21B | 1.10B | 874.10M | 1.47B | 2.65B | 1.75B | 1.04B | 925.60M | 1.14B | 897.00M | 726.60M | 535.50M |
| FCF per Share | 14.50 | 13.06 | 10.04 | 16.18 | 27.40 | 18.02 | 10.67 | 9.13 | 11.17 | 8.75 | 7.35 | 6.31 |
| Book Value | 8.62B | 8.05B | 7.88B | 10.10B | 10.27B | 9.44B | 7.57B | 6.97B | 6.80B | 5.51B | 4.95B | 2.82B |
| Cash & ST Investments | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B | 1.32B | 337.50M | 426.80M | 316.70M | 433.60M | 716.40M | 580.00M |
| ROC Equity | 0.10 | 0.09 | 0.05 | 0.13 | 0.23 | 0.16 | 0.11 | 0.13 | 0.19 | 0.13 | 0.09 | 0.18 |